Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2008 June;50(2) > Panminerva Medica 2008 June;50(2):153-9

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

PANMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6


eTOC

 

REVIEWS  update on CARDIOLOGICAL ISSUES


Panminerva Medica 2008 June;50(2):153-9

language: English

Carotid artery stenting 2008

Van Laanen J., Hendriks J. M., Van Sambeek M. R. H. M.

Department of Vascular Surgery Erasmus University Medical Center Rotterdam, The Netherlands Catharina Hospital, Eindhoven, The Netherlands


FULL TEXT  


In an effort to minimize interventions, in the last decade carotid artery stenting (CAS) has been suggested as an alternative to surgical carotid endarterectomy (CEA) for patients with symptomatic and asymptomatic extra cranial obstructive disease. CAS is relatively new compared to CEA and it should be acknowledged that CAS is an evolving technique. As technology has improved, procedural risks have declined and are approaching those reported for CEA. From the individual randomised clinical trial it can be concluded that in patients at high risk for CEA, CAS is an equivalent, maybe better alternative. In symptomatic patients at standard risk for CEA, CAS has not proven non-inferior, and is worse when performed by relatively inexperienced operators without embolic protection device compared to highly experienced CEA surgeons.

top of page

Publication History

Cite this article as

Corresponding author e-mail